Lack of Effect from a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Efavirenz or Lopinavir-ritonavir

Gelijkaardige items

• Genotypic Resistance at Viral Rebound among Patients Who Received Lopinavir/ritonavir- or Efavirenz-Based First Antiretroviral Therapy in South Africa
  door: Dlamini, J. Nomthandazo, et al.
  Gepubliceerd in: (2011)
• First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting
  door: Clumeck, Nathan, et al.
  Gepubliceerd in: (2014)
• Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer
  door: Rahaba Marima, et al.
  Gepubliceerd in: (2020-08-01)
• Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy
  door: Banda, Clifford G., et al.
  Gepubliceerd in: (2018)
• Association Between Efavirenz-Based Compared With Nevirapine-Based Antiretroviral Regimens and Virological Failure in HIV-Infected Children
  door: Lowenthal, Elizabeth D., et al.
  Gepubliceerd in: (2013)